| Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition S Halldorsson, N Rohatgi, M Magnusdottir, KS Choudhary, T Gudjonsson, ... Cancer letters 396, 117-129, 2017 | 58 | 2017 |
| EGFR signal-network reconstruction demonstrates metabolic crosstalk in EMT KS Choudhary, N Rohatgi, S Halldorsson, E Briem, T Gudjonsson, ... PLoS computational biology 12 (6), e1004924, 2016 | 50 | 2016 |
| Pan-Cancer Analysis of Ligand–Receptor Cross-talk in the Tumor Microenvironment U Ghoshdastider, N Rohatgi, MM Naeini, P Baruah, E Revkov, YA Guo, ... Cancer Research 81 (7), 1802-1812, 2021 | 47 | 2021 |
| Biochemical characterization of human gluconokinase and the proposed metabolic impact of gluconic acid as determined by constraint based metabolic network analysis N Rohatgi, TK Nielsen, SP Bjørn, I Axelsson, G Paglia, BG Voldborg, ... PloS one 9 (6), e98760, 2014 | 37 | 2014 |
| The long non-coding RNA MIR31HG regulates the senescence associated secretory phenotype M Montes, M Lubas, FS Arendrup, B Mentz, N Rohatgi, S Tumas, ... Nature Communications 12 (1), 2459, 2021 | 30 | 2021 |
| CD73 inhibits cgas–sting and cooperates with cd39 to promote pancreatic cancer C Jacoberger-Foissac, I Cousineau, Y Bareche, D Allard, P Chrobak, ... Cancer immunology research 11 (1), 56-71, 2023 | 24 | 2023 |
| Integrative profiling of T790M-negative EGFR-mutated NSCLC reveals pervasive lineage transition and therapeutic opportunities KP Chua, YHF Teng, AC Tan, A Takano, JJS Alvarez, R Nahar, N Rohatgi, ... Clinical Cancer Research 27 (21), 5939-5950, 2021 | 23 | 2021 |
| Kinetic analysis of gluconate phosphorylation by human gluconokinase using isothermal titration calorimetry N Rohatgi, S Guðmundsson, Ó Rolfsson FEBS letters 589 (23), 3548-3555, 2015 | 23 | 2015 |
| A pan-cancer metabolic atlas of the tumor microenvironment N Rohatgi, U Ghoshdastider, P Baruah, T Kulshrestha, AJ Skanderup Cell Reports 39 (6), 2022 | 20 | 2022 |
| Community-reviewed biological network models for toxicology and drug discovery applications AA Namasivayam, AF Morales, ÁMF Lacave, A Tallam, B Simovic, ... Gene regulation and systems biology 10, 51, 2016 | 16 | 2016 |
| A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC) JL Low, DP Lau, X Zhang, XL Kwang, N Rohatgi, JV Chan, FT Chong, ... EBioMedicine 64, 2021 | 15 | 2021 |
| Data-driven inference of crosstalk in the tumor microenvironment U Ghoshdastider, MM Naeini, N Rohatgi, E Revkov, A Wong, S Solai, ... BioRxiv, 835512, 2019 | 7 | 2019 |
| A randomized phase 2 trial of nivolumab versus nivolumab-ipilimumab combination in EGFR-mutant NSCLC GGY Lai, JC Yeo, A Jain, S Zhou, M Pang, JJS Alvarez, NL Sim, AC Tan, ... JTO Clinical and Research Reports 3 (12), 100416, 2022 | 6 | 2022 |
| OA01. 06 Randomised phase 2 study of nivolumab (N) versus nivolumab and ipilimumab (NI) combination in EGFR mutant NSCLC G Lai, J Alvarez, JC Yeo, NL Sim, A Tan, S Zhou, L Suteja, TW Lim, ... Journal of Thoracic Oncology 16 (3), S102-S103, 2021 | 4 | 2021 |
| Randomised phase 2 Study of nivolumab (N) versus nivolumab and ipilimumab (NI) combination in EGFR mutant NSCLC G Lai, J Alvarez, JC Yeo, S Zhou, M Pang, JJS Alvarez, NL Sim, AC Tan, ... Proceedings of the 2020 World Conference on Lung Cancer, online, 28-31, 2021 | 3 | 2021 |
| Abstract LB241: Genomic and molecular features of metachronous metastasis in clear cell renal cell carcinoma MM Naeini, N Rohatgi, U Ghoshdastider, AA Hakimi, AJ Skanderup Cancer Research 81 (13 Supplement), LB241-LB241, 2021 | | 2021 |
| A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)(vol 64 … JL Low, DP Lau, X Zhang, XL Kwang, N Rohatgi, JV Chan, FT Chong, ... EBIOMEDICINE 66, 2021 | | 2021 |
| Corrigendum to ‘A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma … JL Low, DP Lau, X Zhang, XL Kwang, N Rohatgi, JV Chan, FT Chong, ... EBioMedicine 66, 2021 | | 2021 |
| MA13. 08 Genomic and Transcriptomic Features of Distinct Resistance Trajectories in EGFR Mutant Non-Small Cell Lung Cancer (NSCLC) A Tan, KP Chua, Y Teng, A Takano, J Alvarez, R Nahar, N Rohatgi, G Lai, ... Journal of Thoracic Oncology 16 (3), S184, 2021 | | 2021 |
| Abstract PO-055: Pan-cancer metabolic profiling of the tumor microenvironment N Rohatgi, U Ghoshdastider, P Baruah, AJ Skanderup Cancer Research 80 (23 Supplement), PO-055-PO-055, 2020 | | 2020 |
Anders Jacobsen SkanderupGenome Institute of SingaporeVerified email at gis.a-star.edu.sg
